With its unique platform technology based on adult (stem) cells apceth is one of the leading companies in research, development, manufacturing and clinical implementation of innovative cell-based therapeutics.
apceth is implementing innovative cell-based therapies into clinical trials of all phases and stages of development. At present patients are enrolled into a clinical trial for the treatment of advanced gastrointestinal cancer.
apceth provides full GCP/GMP services for cell-based biopharmaceuticals. We established a robust production process in our state-of-the-art facilities which provide a unique combination of GMP and BSL2 laboratories.